Season 2 (2021-2030)

Cardiovascular - Nucleic acid/Virus (1)

Modality Indication Targets Stage Company Project No. Detail
1 GB107, Gene therapy for ischemic limb disease via new expression vector and PT1 technology
Nucleic acid/Virus Peripheral arterial disease, Diabetic peripheral neuropathy HGF Candidate G&P Bioscience HN21C0644
BACK